ZEISS Medical Technology has announced the expansion of its retinal imaging portfolio with the ZEISS ALTA DUO fully automated, compact, multimodal imaging solution. The new device combines OCT and fundus photography within a single imaging system.
Andreas Völker, Head of the Ophthalmology Strategic Business Unit, ZEISS Medical Technology said: “With the introduction of ZEISS ALTA DUO 300, we deliver new customer value by expanding our ZEISS retinal imaging portfolio for eye care professionals, whose needs vary, depending on the patients they serve and services they provide. ZEISS ALTA DUO 300 adds an alternative fully automated, multimodal device to the ZEISS OCT portfolio, complementing the comprehensive CIRRUS solution.”
“Many practices are looking for ways to integrate retinal imaging into everyday patient care through workflows that are efficient, consistent and easy to adopt. By bringing OCT and fundus imaging together with automated acquisition capabilities, ZEISS ALTA DUO 300 helps address those needs while allowing practices to benefit from the broader ZEISS ophthalmic portfolio,” says Anuj Kalra, Head of Chronic Disease Management at ZEISS Medical Technology.
ZEISS says the ALTA DUO 300 is built around four key diagnostic technologies, combined into one automated device. The device offers a fully automated structural OCT with a robust reference database and comprehensive reporting, combined with a true color fundus camera according to the company.
It also includes high resolution AI enhanced OCT-Angiography capability together with full chamber depth anterior OCT scan capability (without the need for external lens applications), providing eye care professionals with multiple diagnostic functionalities in one device.
ZEISS ALTA DUO 300 will be showcased at the European Society of Retina Specialists (EURETINA) congress in Vienna, Austria, from Oct. 1 – 4 and will be available in select markets later in 2026.
